Related references
Note: Only part of the references are listed.Prevalence of age-related macular degeneration among optometric telemedicine users in Spain: a retrospective nationwide population-based study
Miguel A. Zapata et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2021)
Long-term Visual Outcomes after Release from Protocol in Patients who Participated in the Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) Trial
Rebecca N. Evans et al.
OPHTHALMOLOGY (2020)
Cost-Utility Analysis of VEGF Inhibitors for Treating Neovascular Age-Related Macular Degeneration
Gary C. Brown et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2020)
The effect of large-scale anti-contagion policies on the COVID-19 pandemic
Solomon Hsiang et al.
NATURE (2020)
Association between Patient-Reported Outcomes and Time to Late Age-Related Macular Degeneration in the Laser Intervention in Early Stages of Age-Related Macular Degeneration Study
Myra B. McGuinness et al.
OPHTHALMOLOGY RETINA (2020)
Is current age related macular degeneration self-monitoring a good tool for detecting exudative recurrence?
C. Chamard et al.
JOURNAL FRANCAIS D OPHTALMOLOGIE (2019)
Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti-VEGF Drug Type for 1 Year in the IRIS Registry
Prethy Rao et al.
OPHTHALMOLOGY (2018)
Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors
Hemal Mehta et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2018)
Prediction of Individual Disease Conversion in Early AMD Using Artificial Intelligence
Ursula Schmidt-Erfurth et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)
The Potential Importance of Detection of Neovascular Age-Related Macular Degeneration When Visual Acuity Is Relatively Good
Allen C. Ho et al.
JAMA OPHTHALMOLOGY (2017)
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration The Comparison of Age-Related Macular Degeneration Treatments Trials
Maureen G. Maguire et al.
OPHTHALMOLOGY (2016)
Treatment Outcomes After 3 Years in Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen
Nadim Rayess et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)
UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12
Aaron Y. Lee et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2015)
Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design - HOME Study report number 1
Emily Y. Chew et al.
CONTEMPORARY CLINICAL TRIALS (2014)
Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK
Tiarnan D. L. Keenan et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration
Gui-shuang Ying et al.
OPHTHALMOLOGY (2013)
Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
Soraya Rofagha et al.
OPHTHALMOLOGY (2013)
Age-related macular degeneration
Laurence S. Lim et al.
LANCET (2012)
Risk Factors for Conversion to Neovascular Age-related Macular Degeneration Based on Longitudinal Morphologic and Visual Acuity Data
Thomas R. Friberg et al.
OPHTHALMOLOGY (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Intravitreal Bevacizumab and Ranibizumab for Age-Related Macular Degeneration A Multicenter, Retrospective Study
Donald S. Fong et al.
OPHTHALMOLOGY (2010)
NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS
Ninel Z. Gregori et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Results of One-Year's Treatment with Ranibizumab for Exudative Age-related Macular Degeneration in a Clinical Setting
Salomon Y. Cohen et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Socio-economic deprivation and visual acuity at presentation in exudative age-related macular degeneration
N. Acharya et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Association of clinical characteristics with disease subtypes, initial visual acuity, and visual prognosis in neovascular age-related macular degeneration
Yasuhiko Hirami et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2009)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Prevalence of patients presenting with neovascular age-related macular degeneration in an urban population
Claudia Zawinka et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2005)
Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration
TW Olsen et al.
OPHTHALMOLOGY (2004)
Replacing the Amsler grid - A new method for monitoring patients with age-related macular degeneration
A Loewenstein et al.
OPHTHALMOLOGY (2003)
Share Paper
